Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Have you ever heard any publicity is good publicit

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155641
(Total Views: 497)
Posted On: 05/18/2021 7:49:09 AM
Posted By: onestepahead
Re: capable #90701
Have you ever heard any publicity is good publicity. I think it’s great enough people including many doctors and even some politicians badgered the FDA enough that they had to explain themselves. The US FDA explanation would be acceptable if CYDY was trying to get toe fungus cream approved but did not hit primary endpoint. Anyone over those with half a brain would be able to see from all the data that the drug was very effective and beneficial without any safety issues until the patients were stopped being given the drug. Day 0 and Day 7. By day 14 the drug peaked in patients systems and than they began to decline without being given additional leronlimab. It clearly was very beneficial and the FDA is already worried about what they will look like not only in the US but on world stage about why they did not EUA leronlimab. They sent out that letter to explain what we already knew they don’t care about anything but a perfect designed trial that hits any endpoint. It could be out of hospital 2 days early and that’s more important than reduce death by 30-80% in some populations. The failing of endpoints in that trial has been 5x baked into low $3 SP there was no reason for it to drop but all the reasons the past couple Weeks full of great news including huge distribution deals, great financing deals, and getting foot in the door of Brazil and India. I will be loading up on more shares today. This was a short attack using less than 2% of the total float shares able to crash stock 30% is ridiculous.


(3)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us